Jenny Craig, a leader in the weight loss industry, announced today their 2019 ad campaign, which focuses on actual Jenny Craig members and weight loss experts, and their stories of finding health and wellness on the program. Jenny Craig’s mission of helping real people find real results is harnessed in their new campaign, launching digitally and on TV this week. The campaign exclusively features members from across the country who have achieved their weight loss goals using the scientifically proven program.
Jenny Craig hosted a contest this year, which yielded more than 500 applicants, to find authentic stories from members to inspire others on their path to achieve better health. The contest winners were flown to Jenny Craig’s 2019 commercial shoot in Los Angeles for a week and took part in a professional photoshoot as well as received cash and prizes totaling up to $10,000 each. The contest winners shared their experience together and were celebrated for their achievements throughout the week.
To view the multimedia release go to:
https://www.multivu.com/players/English/8469551-jenny-craig-launches-2019-campaign-with-successful-members/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Some of the world’s most famous whisky makers, Johnnie Walker, Bushmills, J&B and Talisker, have harnessed the creative talents of up-and-coming independent film makers around the globe to help inspire people to ‘raise a glass’ to their dads this Father’s Day.
The whisky makers partnered with MOFILM, a global network of more than 45,000 film makers, to seek short films that pay tribute to fathers in a campaign called ‘Raise a glass to your dad’.
MOFILM challenged 20 film makers to create a short piece that told the story of their relationship with their father and how whisky plays a part in that.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/diageo/53835/
